Clinical Trial Update: Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III) [Phase 2, Phase 3]

View source ↗

Summary

A neoadjuvant GTX chemotherapy regimen with chemoradiation is being studied for pancreatic cancer in Stage II/III across Phase 2 and Phase 3 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• GTX

Snippet

Sponsor: Columbia University | Conditions: Pancreatic Cancer Stage II, Pancreatic Cancer Stage III | Phase 2, Phase 3 | Status: UNKNOWN